VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH CML 2022 | Immune dysregulation and clonal hematopoiesis in MDS

Toshio Kitamura, MD, PhD, The University of Tokyo, Tokyo, Japan, comments on immune dysregulation and clonal hematopoiesis (CH) in myelodysplastic syndromes (MDS), discussing the impact epigenetic mutations in hematopoietic stem cells (HSCs) can have on T cells and tumor immunity. This interview took place at the 24th Annual John Goldman Conference on Chronic Myeloid Leukemia (ESH CML) held in Mandelieu-La Napoule, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Advisor for Rigel

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter